HIMS Logo

Hims & Hers Health, Inc. (HIMS) 

NYSE
Market Cap
$4.8B
Sector
Consumer Defensive
Industry
Household & Personal Products
Rank in Sector
7 of 142
Rank in Industry
2 of 18

Largest Insider Buys in Sector

HIMS Stock Price History Chart

HIMS Stock Performance

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, …

Insider Activity of Hims & Hers Health, Inc.

Over the last 12 months, insiders at Hims & Hers Health, Inc. have bought $1.95M and sold $121.57M worth of Hims & Hers Health, Inc. stock.

On average, over the past 5 years, insiders at Hims & Hers Health, Inc. have bought $2.21M and sold $61.85M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Payne Christopher D (director) — $3.9M.

The last purchase of 110,000 shares for transaction amount of $1.95M was made by Payne Christopher D (director) on 2024‑05‑21.

List of Insider Buy and Sell Transactions, Hims & Hers Health, Inc.

2024-10-29SaleChief Legal Officer
2,339
0.0012%
$23.16$54,171-11.42%
2024-10-25SaleChief Commercial Officer
17,304
0.0078%
$22.00$380,6880.00%
2024-10-21SaleChief Commercial Officer
7,500
0.0035%
$22.20$166,500-11.67%
2024-10-16SalePAO
471
0.0003%
$22.64$10,663-5.37%
2024-10-15SaleChief Commercial Officer
75,493
0.0451%
$22.00$1.66M-5.44%
2024-10-15SaleChief Legal Officer
2,339
0.0013%
$20.41$47,739-5.44%
2024-10-14SaleChief Financial Officer
269,739
0.1487%
$20.31$5.48M+6.61%
2024-10-07SaleChief Operating Officer
58,750
0.0312%
$19.57$1.15M+5.45%
2024-10-07SaleChief Financial Officer
9,868
0.0053%
$19.96$196,992+5.45%
2024-10-02SaleChief Financial Officer
11,581
0.0059%
$18.92$219,084+5.01%
2024-10-01SaleChief Legal Officer
2,339
0.0012%
$18.50$43,272+0.67%
2024-10-01SaleChief Executive Officer
333,332
0.1646%
$18.19$6.06M+0.67%
2024-09-20SaleChief Financial Officer
12,651
0.0063%
$16.79$212,356+16.81%
2024-09-20SaleChief Executive Officer
45,767
0.022%
$16.33$747,434+16.81%
2024-09-17SaleChief Commercial Officer
25,550
0.0126%
$16.50$421,575+17.33%
2024-09-17SaleChief Legal Officer
2,339
0.0012%
$16.50$38,594+17.33%
2024-09-17SalePAO
10,017
0.0049%
$16.50$165,281+17.33%
2024-09-16SalePAO
472
0.0002%
$16.45$7,764+15.66%
2024-09-05SaleChief Operating Officer
11,749
0.0056%
$14.40$169,159+29.52%
2024-09-04SaleChief Operating Officer
11,749
0.0056%
$14.65$172,103+27.00%

Insider Historical Profitability

12.16%
WELLS DAVID Bdirector
146195
0.0703%
$23.0843<0.0001%
Okupe OluyemiChief Financial Officer
145763
0.0701%
$23.08118+79.72%
Payne Christopher Ddirector
110000
0.0529%
$23.0810
Dudum AndrewChief Executive Officer
67015
0.0322%
$23.08234<0.0001%
Maltz Jules A.10 percent owner
0
0%
$23.0823+68.81%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$221.38M6.6614.31M+0.97%+$2.12M<0.01
BlackRock$168.01M5.0610.86M+<0.01%+$17,156.23<0.01
Marshall Wace$87.25M2.635.64M+7.04%+$5.74M0.09
Institutional Venture Management Xvi Llc$80.79M2.435.22M-32.37%-$38.68M93.86
Institutional Venture Management Xv Llc$80.79M2.435.22M-32.37%-$38.67M41.61
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.